A B S T R A a . We examined normal human placenta for an immunologic function by measuring the release of soluble inhibitory factor (SIF). SIF is a product of normal T lymphocytes and of the JEG-3 choriocarcinoma cell line, and blocks proliferative and antibody-producing responses of mononuclear cells. SIF can be further characterized by a noncovalently linked subcomponent, lipid suppressor substance. The villous surfaces of six normal human placentae were digested with collagenase to obtain a population of predominantly multinucleated giant cells. These cells were maintained in standard culture for 5 days after which the cell-free conditioned culture medium was assayed for SIF content by measuring suppression of VH] thymidine incorporation into lymphocytes stimulated by low-dose phytohemagglutinin. Undiluted placental SIF induced 88% inhibition of this response (p < 0.001). The placental SIF was found to contain lipid suppressor substance, as does SIF from mononuclear cells. We determined this by thin-layer chromatography where a peak of suppressive activity occurred at Rf 0.32 (PHjthymidine incorporation reduced from 21810 + 308 to 4121 2 214 cpm); this is the position on thin-layer chromatography to which mononuclear cell lipid suppressor substance migrates. Ion exchange chromatography comparing the elution patterns of lymphocyte-SIF and placental-SIF indi: cated that both eluted in the fraction of 40-50 mM P W buffer, further suggesting identity between these two substances. SIF from placental and lymphocyte sources functioned by inducing the presence of suppressor cells in culture. Mononuclear cells were incubated for 48 h in SIF; the resultant cell population reduced [H3]thymidine incorporation into phytohemagglutinin-stimulated lymphocytes from 21170 + 1721 to 8612 2 311 cpm (60% inhibition, p < 0.001). Adherent cells were not required for function of these cells and they were not sensitive to mitomycin C. The placenta helps prevent immunologic rejection of the fetus by several mechanisms; it functions as a barrier, it is devoid of human histocompatibility leukocyte antigen markers and it has immunologic functions. The studies presented herein indicate that the placenta releases a substance that induces the formation of suppressor cells. These data support the hypothesis that placental cells have an immunoregulatory function. (Pediatr Res 23: 212-218, 1988) Abbreviations Ec, effector cells FCS, fetal calf serum PH]TdR, tritiated thymidine
A B S T R A a . We examined normal human placenta for an immunologic function by measuring the release of soluble inhibitory factor (SIF). SIF is a product of normal T lymphocytes and of the JEG-3 choriocarcinoma cell line, and blocks proliferative and antibody-producing responses of mononuclear cells. SIF can be further characterized by a noncovalently linked subcomponent, lipid suppressor substance. The villous surfaces of six normal human placentae were digested with collagenase to obtain a population of predominantly multinucleated giant cells. These cells were maintained in standard culture for 5 days after which the cell-free conditioned culture medium was assayed for SIF content by measuring suppression of VH] thymidine incorporation into lymphocytes stimulated by low-dose phytohemagglutinin. Undiluted placental SIF induced 88% inhibition of this response (p < 0.001). The placental SIF was found to contain lipid suppressor substance, as does SIF from mononuclear cells. We determined this by thin-layer chromatography where a peak of suppressive activity occurred at Rf 0.32 (PHjthymidine incorporation reduced from 21810 + 308 to 4121 2 214 cpm); this is the position on thin-layer chromatography to which mononuclear cell lipid suppressor substance migrates. Ion exchange chromatography comparing the elution patterns of lymphocyte-SIF and placental-SIF indi: cated that both eluted in the fraction of 40-50 mM P W buffer, further suggesting identity between these two substances. SIF from placental and lymphocyte sources functioned by inducing the presence of suppressor cells in culture. Mononuclear cells were incubated for 48 h in SIF; the resultant cell population reduced [H3]thymidine incorporation into phytohemagglutinin-stimulated lymphocytes from 21170 + 1721 to 8612 2 311 cpm (60% inhibition, p < 0.001). Adherent cells were not required for function of these cells and they were not sensitive to mitomycin C. The placenta helps prevent immunologic rejection of the fetus by several mechanisms; it functions as a barrier, it is devoid of human histocompatibility leukocyte antigen markers and it has immunologic functions. The studies presented herein indicate that the placenta releases a substance that induces the formation of suppressor cells. The placenta has attracted the attention of immunologists looking for an explanation for resistance of the fetal allograft to immunologic rejection by its mother. Studies exploring this topic have been reviewed by Johnson et al. (1) . Foremost in theories explaining the phenomenon is the observation that the trophoblastic membrane appears devoid of MHC markers (2, 3) suggesting that the tissue is not recognized by maternal immune mechanisms. Tissue from uterine decidual gland epithelium also lacks maternal MHC antigens (4). Malignant and abnormal placental tissue partially express MHC markers, especially P2 microglobulin (5, 6) , suggesting that normal trophoblast actually suppresses the expression of these antigens. Other investigators have either produced evidence that the trophoblast can provoke an immune response (7) or, in contrast, is incapable of doing so and resists lysis (8) . Human trophoblastic tissue continuously enters the maternal circulation and may remain sequestered within lung (9), but the significance of this event is not apparent. These trophoblastic fragments do not stimulate an immune or inflammatory response.
Several authors (10, 11) have shown that the ectoplacental cone portion of mouse placenta can inhibit some immune responses while enhancing others, indicating that the placenta can directly influence lymphocyte function. Moreover, soluble substances that stimulate immunologic responses are released by placental cells; cultures of transformed and normal trophoblastic cells release colony-stimulating factor (1 2), a cytokine that promotes maturation of polymorphonuclear cell cultures.
We have shown previously that the choriocarcinoma-derived cell line, JEG-3, releases SIF into culture fluid (1 3). SIF nonspecifically suppresses lymphocyte proliferation and antibody synthesis (14) . It is released by dividing T and null cells, but not by B cells or continually growing B or T cell lines. Monocyte cultures do not generate SIF in the culture medium. SIF is distinguished by a dual structure comprising a protein moiety of 130-150 kD and a glycolipid, LSS (1 5). SIF has been found in normal human plasma and serum, suggesting that it is released into the circulation (16) . In this study, we explored the postulate that SIF might be released by the normal human placenta, thus supporting the hypothesis that the placenta has an immunologic function.
METHODS

Placental cell cultures.
Six placentae from six uncomplicated pregnancies were obtained at normal delivery within 30 min of expulsion and studied separately. Human clinical investigation committee approval was obtained for this study. The villous surface was washed with sterile saline and dissected using sterile techniques. The tissue was washed with PBS to remove blood and was cut into small pieces. Microscopic slides were prepared to note the presence of giant cells in situ. The slices were disrupted with collagenase (0.5%) for 30 min in a shaker water bath at 37" C to free cells. Noncellular debris was removed by filtration over gauze. The cells were washed twice in HBSS and resuspended in RPMI 1640 with added 10% heat inactivated human serum from donors AB Rh+ blood type (AB+), 2 mM L-glutamine, 100 pg/ ml streptomycin, and 100 U/ml penicillin (complete medium). Tissue culture flasks (25 cmZ area) were coated with fibronectin (kindly supplied by Dr. Francois Booyse, Michael Reese Blood Bank and Research Foundation) at room temperature for 30 min. Cell suspension was added to the flasks and cells were obtained as they settled. We determined that 5 min was optimal for adherence of multinucleated giant cells. There was minimal adherence of fibroblasts and endothelial cells after 5 min. Lymphocytes and monocytes were not present in these preparations. The adherent cells were washed thoroughly to remove nonadherent cells and red blood cells and complete medium was added (10 m1/25 cm2). Cultures were maintained at 37" C in humidified air with 5% COz and were refed after 24 h. Duration of culture was 4 days, after which the conditioned media (placental SIF) were filtered (0.45 p) and stored at 4" C until used. For some experiments, culture fluid was sampled at 24-h intervals for the total duration of culture. Media treated at 60" C for 15 min were also assayed for SIF activity. Control culture supernatant fluid was derived from smooth muscle cell and endothelial cell cultures derived from normal skin biopsy. These were kindly donated by Dr. F. Booyse and were prepared on fibronectincoated cloning cover slips using techniques described elsewhere (1 7). ' preparation of lymphocyte SIF. Thirty to 40 ml of whole blood from normal healthy volunteers was diluted with an equal volume of HBSS and fractionated by density gradient over FicollHypaque (Pharmacia, Piscataway, NJ). MNC settling at the interface were washed three times in HBSS and resuspended in complete medium at lo6 cells/ml. SIF-containing culture fluid was prepared by MLR as described elsewhere (14) . Briefly, MNC were derived from unrelated donors and each resuspended in complete medium at 5 X lo6 cells/ml. The cell suspensions were mixed in equal volumes and cultured for 5 days in humidified air with 5% C02 at 37" C. The cultures were terminated by centrifuging at 900 X g for 15 min; the supernatant fluid was filtered (0.45 p) to remove cell debris and was stored at 4" C until used.
Negative control cultures were prepared from MLR where both parties of cells were irradiated with 10,000 rad. We have previously (14) demonstrated that irradiated lymphocytes do not release SIF.
Purification of SIF and LSS. SIF was isolated by ion-exchange column chromatography using DEAE Sephadex (Pharmacia). Placental media or MLR culture fluid were dialyzed against starting buffer (10 mM POa-at pH 7.6) and run into the column. SIF was eluted in a linear gradient of PO4-buffer from 30 to 150 mM at pH 7.0. Fractions were pooled according to the previously noted elution pattern of SIF (16) . The fractions were concentrated to original volume over a membrane of nominal cutoff 10,000 daltons, dialyzed against two changes of 2 0~ volume HBSS and one of RPMI 1640. AB+ serum (10%) was added, and the fractions were stored at 4" C until used.
LSS was derived by extraction of placental SIF and lymphocyte SIF into ch1oroform:methanol as described previously (15) . Fifteen ml of SIFcontaining fluid were diluted with an equal volume of distilled water and adjusted to pH 9 with KOH-borate buffer.
Thirty ml of C:M 1 : 1 was added slowly with mixing. The mixture was shaken vigorously and centrifuged at 6000 x g for 30 min to break the emulsion. The upper methano1:water phase was dried by rotary evaporation under vacuum. The residue was extracted into C:M to remove LSS from salt. Further purification was achieved by preparative TLC. Silica gel 60 plates (Scientific Products, McGaw Park, IL) were washed in C:M and allowed to dry. The LSS-containing extract was streaked in 1 cm bands at 5 &and. The plates were developed with C:M:water 60:38:8 to within 2.5 cm of the top. A 5 x 20 cm plate was run in parallel and charred with 50% sulfuric acid to identify bands. The mobility fraction relative to the solvent front (Rf) at 0.31-0.33 was scraped and eluted sequentially with C:M:water 155: 1, C:M:water 5: 1 5: 1, and methano1:water 9: 1. The remainder of the plate was scraped in 0.5-cm bands. The eluates were pooled, dried to remove all traces of solvent, and LSS was redissolved in complete medium and stored at 4" C until used. Control extractions were performed on control medium after passage through an ion exchange column or with solvent alone.
Assay for SIF and LSS. MNC were derived from healthy donors and resuspended in complete medium at lo7 cells/ml. One donor was used in each of six experiments to test samples of placental SIF, lymphocyte SIF and control simultaneously. Triplicate 0.2-ml aliquots of each test and control sample were placed in 96-well microtiter plates. Dilutions of the test samples were made using complete medium. Twenty pl of cell suspension were added to each well, giving lo5 cells/well. The cells in culture were stimulated with 20 p1 of PHA at a dose (0.95 pg/ml) previously titrated by dilution curves to give 0.25 of the maximum incorporation of [3H]TdR. Cultures were maintained at 37" C in humidified air with 5% COZ for 4 days, pulsed with [3H]TdR (20 pCi/ml; 50 Ci/mol, New England Nuclear, Boston, MA) and harvested 18 h later onto filter discs using a Titertek harvester (Flow Labs, Rockville, MD). Uptake of ['HITdR into new DNA was measured by counts remaining on the filter discs using a fluor-based cocktail (RPI-3a, Research Products International, Mount Prospect, IL). LSS activity was measured with a shorter culture period of 48 h, as we have previously noted peak suppression by LSS at this time (14) .
Fibroblast cultures were kindly donated by Dr. F. Booyse and were prepared as previously described (17) . Once the cultures were established, the culture medium was replaced with 10 ml of complete medium on SIF-containing media. The flasks were cultured at 37% in humidified air with 5% C02 for 4, 16, and 72 h. The incorporation of [3H]TdR into new DNA was measured after 4 h incubation.
We measured the effect of varying the concentration of PHA on the suppression induced by SIF. The volume of the SIFcontaining fraction from DEAE Sephadex chromatography was kept constant. PHA was used at 0.95, 1.25,2.0, and 2.25 pg/ml. The assay was performed as above.
Induction of suppressor cell activity. The method of Shou et al. (18) was modified as follows. In the first phase MNC were derived from peripheral blood of normal, healthy volunteers and suspended at 2 X lo7 cells/ml in complete medium. Nine-tenths ml of control and test culture fluids were placed separately in duplicate wells of a 24-well cluster plate (1 cm2 well) (Flow Labs) and 0.1 ml of cell suspension was added. The cultures were rocked at 4-6 oscillation/min in humidified air with 5% COz at 37" C for 2 days. The MNC (Ec) were then washed three times in HBSS and once in RPMI and resuspended in complete medium at lo6 cells/ml.
A titration curve of the effect of SIF containing fluids in inducing suppressor cell function was obtained by using dilutions of placental SIF and lymphocyte SIF in control media. This procedure was otherwise identical with the generation of Ec above.
Role of adherent cells. MNC, as above, were suspended at lo7 cells/ml in HBSS with 20% heat inactivated FCS and incubated in plastic Petri dishes at 37" C in humidified air with 5% C02 for 45 min. Nonadherent cells were removed by aspiration and washing of the Petri dishes with HBSS. The nonadherent cells were resuspended in HBSS with 20% FCS and the procedure repeated. Adherent cells were removed using a rubber policeman. Adherent and nonadherent cells were adjusted to a density of 2 x lo7 cells/ml. The adherent cell fraction showed 95% nonspecific esterase staining (19) . Nonadherent cell fraction was <0.1% positive for nonspecific esterase. Adherent cells were added to form 0, 2,4, 8, and 10% of the total number of cells in suspension, keeping the final density at 2 x lo7 cells/ml. Onetenth ml of these cell suspensions was added to 0.9 ml of placental SIF, lymphocyte SIF, or control medium and plated into I cm2 wells of a 24-well cluster plate as above. Each concentration of adherent cells for each of the three groups was tested in duplicate.
Assay for suppressor cell activity. The presence of suppressor cell activity (Ec) cultures was assessed by a second phase culture to evaluate reduction of [3H]TdR incorporation into fresh MNC. R, were derived from peripheral blood of a healthy donor, unrelated to donors used in the first phase. One donor was used to assay paired samples of Ec derived in placental SIF, lymphocyte SIF, and control media. Six separate experiments were performed. These RC were suspended in complete medium at lo6 cells/ml and placed in microtiter wells at 10' cells/well. Ec from each sample of placental SIF, lymphocyte SIF, and control were added after washing three times in HBSS in ratios of Ec:Rc at 0: 1, 1: 1, 1 :2, 1:4, 1 :8, and 1: 16. Each was tested in triplicate. Cultures were stimulated with PHA at a dose (0.95 pg/ml) that yielded 0.25 peak response (determined from dilution curves) and maintained at 37°C in humidified air with 5% C02. After 4 days, the cultures were pulsed with [3H]TdR, harvested onto filter disks 18 h later, and counted for [3H]TdR incorporation.
Eflect of mitomycin C. In some experiments EC were treated with mitomycin C, 50 pg/106 cells for 30 min before evaluation for the presence of suppressor activity. These cells were washed and assayed for comparison with Ec that were not treated with mitomycin C in paired experiments using one group of Rc for each of four experiments. Each sample was tested in triplicate. This group of experiments was performed at a ratio of Ec:Rc of 1:l.
Calculation of results. All results were expressed as mean f SEM or as %I, where:
I net cprn in test % I = 1 -net cprn in control Significant suppression was determined at the p 5 0.05 limit by comparing paired samples of placental SIF or lymphocyte SIF and control using the paired Student's t test.
RESULTS
When placental villi were dissected and cells dispersed with collagenase and allowed to settle on fibronectin-treated culture flasks, we noted that multinucleated giant cells settled within 5 min, while few fibroblasts and endothelial cells were present. Lymphocytes and monocytes were not present. The multinucleated cells were firmly adherent; red cells were removed by washing the flask. Multinucleated giant cells formed 80-90% of the placental adherent cells in culture (Fig. 1) . The remainder were fibroblasts (5-10%) and endothelial cells. Figure 1 
Conditioned medium from these cultures was assayed for an effect in suppressing [3H]TdR incorporation into MNC stimulated with PHA (Table 1) . Undiluted placental SIF induced 98%I of [3H]TdR uptake. This activity was completely removed by heating to 60" C for 15 min. These are conditions under which SIF activity is destroyed (Table 1) as we have previously demonstrated (1 4) . Aliquots sampled at 24-h intervals demonstrated the appearance of suppressor activity (placental SIF) within 24 h of establishing placental cell cultures, with a maximal effect after 48 h (as seen in Table I) , and the suppressive effect remained constant thereafter. Neither smooth muscle cells nor skin endothelial cells released SIF into culture fluid. A dilution curve demonstrating titration of the suppressive effect of placental media is seen in Figure 2 .
We evaluated the effect of placental SIF on fibroblast cultures. Baseline counts of [3H]TdR uptake into dividing trophoblasts were 10210 f 1370 cpm. This was reduced to 731 1 f 78 cprn (30%I, n = 4) after 4 h exposure to SIF, to 4210 f 772 cprn (59%I, n = 4) after 16 h, and to 5217 f 560 cprn after 72 h (49%I, n = 4).
When we varied the concentration of PHA relative to SIF, a titration effect was seen. Using 0.95 pg/ml, we obtained 89% suppression of [3H]TdR incorporation (266 10 + 6 10 1 cprn reduced to 2927 f 1021 cprn). At 1.25 pg/ml, 50%I (13305 + 23 11 cpm) was seen and 30%I (186278 + 3 110 cpm) at 2.0 pg/ ml and 28%I (19 159 f 1020 cpm) at 2.25 pg/ml. Extraction of placental-SIF into C:M and purification of this extract by TLC using silica gel yielded a fraction at Rf 0.32 that suppressed [3H]TdR uptake into PHA-stimulated cells after 2 days of culture from 218 10 f 308 to 4121 + 2 14 cpm (82%I, p < 0.001). This chromatographic pattern of suppressor activity was identical to that of LSS extracted from lymphocyte SIF (Fig.  3) . No other regions of the TLC plate suppressed significantly.
MNC were incubated with control media, placental SIF, and lymphocyte SIF to assess the induction of a population of suppressor cells (Ec). These were tested on responder MNC (Rc) stimulated with PHA at a dose (0.95 pg/ml) determined from titration curves to give 0.25 of peak response. Similar experiments were performed using placental LSS and lymphocyte LSS. These results are shown in Table 2 . Placental SIF and lymphocyte SIF induced the formation of Ec that suppressed significantly and were still active at a ratio of Ec:Rc 1:4. These cells were not sensitive to mitomycin C; there was no significant difference between mitomycin C-treated and nontreated groups. Ec generated in complete medium or control medium (irradiated MLR) did not suppress 13H]TdR uptake into Rc. Ec generated in placental LSS or lymphocyte LSS did not suppress [3H]TdR uptake into Rc.
SIF from placental and lymphocyte cultures were partly purified by ion-exchange chromatography. The results of this purification are presented in Figure 4 as %I of [3H]TdR uptake into PHA-stimulated MNC. Placental SIF and lymphocyte SIF eluted in the 40-50 mM POT buffer fraction. Placental SIF in this fraction reduced [3H]TdR incorporation into PHA-stimulated MNC from 27121 f 1820 to 3210 f 391 cpm (mean f SEM, n = 6 experiments each in triplicate; 89%I, p < 0.00 1). Lymphocyte SIF reduced 27121 + 1820 to 5171 + 1002 cpm (81%I, p < 0.001, n = 6).
The SIF-containing fractions from ion-exchange chromatography of placental culture and MLR were also assessed for induction of suppressor Ec. Measured at a ratio of Ec:R, 1:1, placental-SIF (purified) induced the formation of Ec that reduced We evaluated the role of adherent cells in the production of suppressor Ec. Adherent cell-depleted cultures contained fewer than 1% nonspecific esterase positive cells. These studies were performed with Ec generated in control media, placental-SIF, and lymphocyte SIF and evaluated at a ratio of Ec:Rc of 1: 1 and 1:4. The results seen in Table 3 indicate that adherent cells were not required for the production of suppressor Ec in this system. Moreover, adding adherent cells at concentrations ranging from 2 to 10% of total cells did not affect the degree of suppression induced by Ec. There was no detectable difference between placental-SIF or lymphocyte-SIF in this assay. Control media did not induce Ec in the presence or absence of adherent cells. 7 Ec were generated by incubation for 48 h in media listed. Rc were from an unrelated donor.
$Mean f SEM, n = 6 experiments, each in triplicate. § Not done.
I( SIF was used undiluted as generated at original culture volume/cell ratio.
Q p < 0.001 by paired Student's t-test compared to control values. ** p < 0.05. Mitomycin C did not significantly alter suppression induced by Ec. onstrated multinucleated giant cells (Fig. 1 ). An intact cell membrane can be seen in Figure 1 , making it unlikely that this appearance is due to cell aggregation. When these cells were allowed to settle in fibronectin-coated tissue culture flasks for 5 min, the predominant population was multinucleated cells, while fibroblasts, endothelial cells, and red cells were removed by washing the culture flasks with complete medium. For the first 4-5 days of culture, the dominant cells were multinucleated and these cells remained viable as determined by trypan blue exclusion. If any lymphocytes had in fact been present, their numbers would have been too few to contribute SIF. Unstimulated multinucleated cells released measurable suppressor activity (placental-SIF) after 24 h in culture, Aliquots of media from these cultures were taken at 24-h intervals. There was no increase in suppressor activity beyond the level generated in the first 24-h period. Release of SIF by placental giant cells without prior activation is distinct from MLR, where 5-6 days of culture are required to generate SIF (14) . This time interval correlates with activation of lymphocytes by MLR Shou et al. (20) have demonstrated that unstimulated lymphocytes in culture produce a suppressor substance that inhibits MLR in the proliferative phase, indicating that lymphocytes can release suppressor substances without stimulation.
The suppressor activity in placental giant cell culture media presented characteristics of SIF. The activity was destroyed by heating to 60" C for 15 min, as we have noted for SIF (14) . During ion-exchange chromatography of placental cell culture fluids, SIF-like activity eluted only in the range of 40-50 mM POP buffer; i.e. the fraction of the eluate in which SIF is found (16) . SIF appears to consist of a protein noncovalently linked to LSS. The exact relationship between the protein component of SIF and LSS is not clear, however. The two molecules coelute from an ion exchange gradient after molecular seiving. Preliminary purification studies using SDS polyacrylamide gel have isolated SIF to two protein bands that migrate in the region of substances of 130,000 kD (data not shown). We have eluted LSS from this region, further suggesting that LSS forms part of the SIF molecule. The origins of the protein component of SIF and of LSS are not apparent from our data. The complete SIF molecule and LSS do not have the same range of function. Intact SIF induces a population of cells with suppressor function and suppresses both antigen-and mitogen-induced thymidine incorporation. LSS, once extracted from SIF, suppresses only PHA and does not stimulate the formation of suppressor cells. The extraction process we use to recover LSS is destructive to the protein. Thus we have been unable to evaluate the role of the protein moiety alone. It may be, however, that LSS and the protein are necessary to induce suppressor cell activity.
Others have also noted different suppressive effects by components of suppressor substances. Green et al. (21) described SISS, produced in response to concanavalin A. There were two components, SISS-T and SISS-B. SISS-T suppressed mitogen and antigen driven T-cell proliferation. This factor had a smaller apparent diameter than SIF, 30-45 kD. It was not cytotoxic and was unstable at 56" C , as is SIF. This suppressor substance was derived from adherent cells and mononuclear cells are required for its function, in contrast to SIF. Schnaper et al. (22) have shown that SIRS, produced by mouse spleen cells, can be blocked by levamisde, vitamin C, and catalase. This implies that SIRS requires granulated cells. Such c e k are not necessary for SIF function.
We confinned the presence afLSS in placental-SIF by preparative TLC. A C:M extract of placental-SIF was purified by TLC, and activity was found as a band of suppressor activity in the rw*m oTRf 0.32 as noted previausip fm LSS from MLR-culture media ( l5). LSS appears to be a gbyealipid (Wolf RL, unpublished data) that suppresses lymphocyte prorzerative responses in&-pendent of the protein moiety of STF.
GIycolipids are normal cornpcmwfs of lymphocyte meenh a m s (23, 24) and GMI is f o d in be tissue and in the TbyI marker of mouse lymphocyte membrane (25, 26) . LSS may be a glycolipid common to lymphocyte and placental cell membranes which is shed into culture. McIntyre and Faulk (27, 28) have demonstrated novel alloantigens that are shared by lymphocytes and trophoblastic cells. Moreover, antibodies to these trophoblast-specific antigens suppress MLR, providing further evidence for membrane structures common to trophoblastic cells and lymphocytes. Fatty acids inserted into lymphocyte membranes alter cell function as measured by inhibition of rosette formation (29) and blocking in the migration inhibition assay (30) . LSS may suppress proliferation by altering lymphocyte membrane function or fluidity. The exact source of the protein component of SIF and the mechanism through which LSS becomes associated with this molecule are not clear. SIF is released by lymphocytes but not by B cell lines (14) or endothelial or smooth muscle cell cultures, so it would appear that release of this molecule is not solely a function of cell division or cell degeneration. Moreover, lymphocytes irradiated and kept in culture alone or in irradiated mixed lymphocyte culture do not release SIF (14) . SIF will suppress the incorporation of thymidine into fibroblasts as well as lymphocytes. This is a noncytotoxic mechanism. Inasmuch as SIF added just before pulsing with [3H] TdR does not cause a reduction of cpm, we infer that it does not simply block thymidine but reduces proliferation and DNA synthesis. This mechanism requires further elucidation. The placenta has recognized immunologic function. The studies of Barg et al. (I I) demonstrated that ectoplacental cones of mice decreased T cell-dependent cytotoxicity. McIntyre and Faulk (27) found a protein from trophoblast membrane that blocks MLR, but not mitogen responses, distinguishing it functionally from SIF. While trophoblastic membrane is devoid of human histocompatibility leukocyte antigen markers (2-4), paternal antigens (H2K) are found on murine trophoblast (3 l) and placenta will absorb anti-H2K antibody (32) . Thus, the complexities and range of the immune reactions to the placental membrane and the placental factors that modulate immune responses do not seem to have been completely defined.
We have noted that SIF added at 24-h intervals to MNC cultures stimulated with tetanus toxoid inhibited the toxoid stimulation only after 24 h of culture (16) . We inferred from these data that SIF functioned via a second cell population that required at least 24 h to appear in culture. Accordingly, we studied placental SIF for an ability to produce suppressor cells. SIF induced the emergence of such a population of lymphocytes in normal MNC after 48 h in culture. The presence of suppressor cells was measured by reduction of [3H]TdR incorporation into lymphocytes stimulated with a suboptimal concentration of PHA intended to produce 0.25 maximal response. The suppressor cells generated in response to SIF inhibited in a dose-dependent manner. These cells did not suppress in our assay system when the PHA was used at an optimal concentration (2.25 pg/ml). The effect could be titrated by varying the concentration of PHA implying that the effect related to the number of cells stimulated, with a greater number of cells stimulated by optimal dose PHA. The low-dose PHA responder cells may be fewer in number and thus more readily suppressed, or they may be distinct from fulldose PHA responders; our data do not distinguish these possibilities. In contrast to SIF, LSS extracted from the molecule did not induce suppressor cells. The reason for this difference is not clear, but the presence of LSS in the SIF molecule may be essential for induction of suppressor cells by SIF. Because our methods of removing LSS from SIF are destructive, we were unable to determine whether the protein component of SIF alone would induce suppressor cell activity.
We noted that the presence of adherent cells was not necessary for the induction of a suppressor cell population in response to SIF. The addition of adherent cells in concentrations ranging from 2 to 10% of total Ec did not alter the suppressor activity induced among Ec by SIF. The suppressor cells were not affected by treatment with mitomycin C, indicating that DNA synthesis was not needed for expression of suppressor function.
Suppressor lymphocytes may be instrumental in maintaining the fetal allograft. However, conflicting data have been generated regarding this role of suppressor cells. Pavia and Sites (33) did not detect an increase in suppressor cells during pregnancy, while others, using different assay systems, noted that suppressor lymphocytes in the spleen of pregnant mice were increased in comparison to nonpregnant controls (34, 35) . Moreover, spleen cells of these mice will block cytotoxity (36) . Smith and Sternlicht (37) have identified a population of cells in mouse spleen that are responsible for alteration of the primary response in pregnant mice. Suppressor cell activity may be detected under several circumstances, and a number of soluble substances induce the appearance of suppressor cells in vitro. Antigen-antibody complexes (38) , interferon (39) , maternal IgG (40) , and concanavalin A (1 8) exhibit suppressor function via an intermediary suppressor cell population.
Thus, suppressive substances, such as SIF, that are released by placental cells, may induce suppressor cells in vivo, contributing to the maintenance of the fetal allograft.
